Literature DB >> 23447344

GLP-1 based agents and acute pancreatitis : drug safety falls victim to the three monkey paradigm.

Edwin A M Gale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23447344     DOI： 10.1136/bmj.f1263

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Incretin-based therapies: facing the realities of benefits versus side effects.

Authors:  Harold E Lebovitz
Journal:  Diabetes Technol Ther       Date:  2013-10-10       Impact factor: 6.118

Review 2.  Incretin-based therapies and acute pancreatitis risk: a systematic review and meta-analysis of observational studies.

Authors:  Carlo B Giorda; Carlotta Sacerdote; Elisa Nada; Lisa Marafetti; Ileana Baldi; Roberto Gnavi
Journal:  Endocrine       Date:  2014-08-22       Impact factor: 3.633

3.  Distal gastrectomy in pancreaticoduodenectomy is associated with accelerated gastric emptying, enhanced postprandial release of GLP-1, and improved insulin sensitivity.

Authors:  Stefan Harmuth; Marlene Wewalka; Jens Juul Holst; Romina Nemecek; Sabine Thalhammer; Rainer Schmid; Klaus Sahora; Michael Gnant; Johannes Miholić
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

4.  Understanding drug preferences, different perspectives.

Authors:  Peter G M Mol; Arna H Arnardottir; Sabine M J Straus; Pieter A de Graeff; Flora M Haaijer-Ruskamp; Elise H Quik; Paul F M Krabbe; Petra Denig
Journal:  Br J Clin Pharmacol       Date:  2015-06       Impact factor: 4.335

5.  Increased Serum Insulin Exposure Does Not Affect Age or Stage of Pancreatic Adenocarcinoma Diagnosis in Patients With Diabetes Mellitus.

Authors:  David T Chao; Nilesh H Shah; Herbert J Zeh; Nathan Bahary; David C Whitcomb; Randall E Brand
Journal:  Pancreas       Date:  2016-02       Impact factor: 3.327

6.  Q&A: insulin secretion and type 2 diabetes: why do β-cells fail?

Authors:  James Cantley; Frances M Ashcroft
Journal:  BMC Biol       Date:  2015-05-16       Impact factor: 7.431

Review 7.  The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A "Me Too" or "the Special One" Antidiabetic Class?

Authors:  Ricardo Godinho; Cristina Mega; Edite Teixeira-de-Lemos; Eugénia Carvalho; Frederico Teixeira; Rosa Fernandes; Flávio Reis
Journal:  J Diabetes Res       Date:  2015-05-17       Impact factor: 4.011

8.  Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice--EVIDENCE: A Prospective, 2-Year Follow-Up, Observational, Post-Marketing Study.

Authors:  Jean-Francois Gautier; Luc Martinez; Alfred Penfornis; Eveline Eschwège; Guillaume Charpentier; Benoît Huret; Suliya Madani; Pierre Gourdy
Journal:  Adv Ther       Date:  2015-09-30       Impact factor: 3.845

9.  Metformin Ameliorates Dysfunctional Traits of Glibenclamide- and Glucose-Induced Insulin Secretion by Suppression of Imposed Overactivity of the Islet Nitric Oxide Synthase-NO System.

Authors:  Ingmar Lundquist; Israa Mohammed Al-Amily; Sandra Meidute Abaraviciene; Albert Salehi
Journal:  PLoS One       Date:  2016-11-07       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.